RheumNow Podcast - Speak Up! (6.18.2021)
Jun 18, 2021
Dr. Jack Cush talks on education, engagement and the challenge of speaking up, if not first!
Read Article
#EULAR2021: "I am an advocate for smart T2T, not a mathematical T2T approach." - Dr. Filip van den Bosch @RheumNow
Meral K. El Ramahi, MD @MeralElRamahiMD( View Tweet )
Jun 02, 2021
RheumNow Live 2021 Now Available for All
May 14, 2021
RheumNow Live (RNL) for 2021 was held March 20 - 21 in Fort Worth, TX, and now all can partake in the meeting - by video, podcast or by signing up for Tuesday Nite Rheumatology (TNR).
RNL has finished its 3rd year as a hybrid meeting, with the live meeting streamed to hundreds at home
Read Article
CDC: Fully Vaccinated Can Shed Masks and Resume Travel
May 13, 2021
The U.S. Centers for Disease Control and Prevention (CDC) today updated COVID guidance such that fully vaccinated people do not need to wear masks outdoors, can avoid wearing them indoors in most places,
Read Article
RheumNow Podcast – Mistakes with Steroids
Apr 08, 2021
Dr Jack Cush gives his spin on this week's RheumNews and Rheum Research from RheumNow.com.
Read Article
RheumNow Podcast – Sweet Lies or Hard Truths? (2.26.2021)
Feb 26, 2021
Dr. Jack Cush reviews and discusses the news and Journal reports from the past week on RheumNow.com.
Read Article
2020 Rheumatology Year in Review
Jan 14, 2021
2020 was historic, memorable and game-changing. Under the cloud of COVID-19, there were many significant and memorable advances and setbacks for the rheumatology world. In our accounting of most read articles for 2020, (not surprisingly) 17/20 were COVID-related. Below, are our top news items
Read Article
Best of 2020: The Nine Lives of Hydroxychloroquine (Updated)
Dec 21, 2020
Hydroxychloroquine is one of many medications frequently used in rheumatology practice. Its remarkable versatility is attested by its routine use in lupus, in patients with an autoimmune coagulopathy, in patients with rheumatoid arthritis, as well as in those with a low-level inflammatory
Read Article
Encouraging Rheumatology Fellowship Match for 2021
JJ Cush and ACR Press Release
Dec 18, 2020
The results of the National Residents Matching Program (NRMP) match in rheumatology are out and show that rheumatology fellowship was both competitive and highly sought after.
Rheumatology was among the most competitive of subspecialties, that included Allergy and Immunology,
Read Article
RheumNow Podcast – Back Talk: Questions from Listeners (10.23.20)
Oct 23, 2020
Dr. Jack Cush reviews the news, journal reports, survey results and "Back Talk" questions from Rheums.
Read Article
High Burnout Rates Among Rheumatologists
Oct 22, 2020
Bergman and colleagues have studied a large cohort of US rheumatologists and found that nearly half meet at least one criterion defining "burnout" among physicians.
While attending the annual rheumatology review meeting in 2019 (Rheumatology Winter Clinical Symposium) 128
Read Article
Clinical Trial Boom or Bust in Severe COVID-19
Oct 20, 2020
A number of recently published clinical trials are further defining the efficacy and outcomes of tocilizumab or remdesivir in treating SARs-CoV-2 infection.
Remdesivir
Read Article
TNF Inhibitors or non-TNF Biologics - First Best Choice?
Oct 18, 2020
Prospective observational findings from the CORRONA registry of rheumatoid arthritis (RA) patients compared clinical outcomes between initial aggressive therapy using either a tumour necrosis factor inhibitor (TNFi) or a non-TNFi (biological disease-modifying antirheumatic drugs (bDMARDs) and
Read Article
RheumNow Podcast – Bad Disease & Bad Outcomes (10.9.20)
Oct 08, 2020
Dr. Jack Cush Reviews the news and journal articles from the past week on RheumNow.com.
Read Article
RheumNow Podcast – The Bad News That’s Fit to Print (8.21.20)
Aug 20, 2020
Dr Jack Cush reviews the news and journal reports from the past week on RheumNow: filgotinib rejection, delays in diagnosis, metformin benefits COVID, Abx and IBD, and UPA beats MTX.
Read Article
NY Times article about a "guy and aching legs". 48 yrs old w/ myalgias, wt loss, SOB, sinusitis, high inflammatory markers, pulmonary infiltrates, microscopic hematuria, red & swollen ears; but no fever/chills. You're a rheumatologist, you know the Dx. https://t.co/fbrRMNA5u4 https://t.co/JFOcM0MBxB
Links:
Dr. John Cush @RheumNow( View Tweet )
Aug 17, 2020
RheumNow Podcast – Why Do We Love Rheumatology Fellows? (8.7.20)
Aug 06, 2020
Dr. Jack Cush reviews why we all love our rheumatology fellows and our best advice for them stemming from these articles.
Read Article
Virtual Video Joint Exam Pearl #5: The worst/most ineffective Virtual visits done with the Patient (or MD) driving in their CAR for the virtual visit!! Amazingly I have had a half dozen of these & requested the patient pull over so I could deliver a rheum Citation.
Dr. John Cush @RheumNow( View Tweet )
Aug 04, 2020
Virtual Video Joint Exam Pearl #4: Professor Paul Emery was right! THe MCP squeeze (done by the patient) and MTP squeeze is fairly predictive of RA/inflammatory arthritis AND outperforms the "Finger" (distal hand) squeeze. Hence the MCP/MTP is my main squeeze!
Dr. John Cush @RheumNow( View Tweet )
Aug 04, 2020
Virtual Video Joint Exam Pearl #1: pain elicited by cervical lateral bending (in someone w/ otherwise normal Cx ROM) is highly correlated with Tender trigger points in the neck region (hence #FM)
Dr. John Cush @RheumNow( View Tweet )
Aug 04, 2020
Fighting Hydroxychloroquine Misinformation
Aug 03, 2020
JAMA Internal Medicine has posted an Editor's note on the use of hydroxychloroquine for COVID-19; noting the sequence of dysfunction since the president promoted its use on March 21, 2020, when he said “What do you have to lose? I’ll say it again: What do you have to lose? Take it
Read Article
More Rheumatology Fellow Advice from the Mentors
Aug 03, 2020
If you’re looking for some great advice to consider or rebuke, here is the generous guidance of nearly two dozen leaders in rheumatology who sincerely offer you their wisdom and best wishes.
Read Article
ICYMI: The Nine Lives of Hydroxychloroquine (Updated)
Jul 07, 2020
Hydroxychloroquine is one of many medications frequently used in rheumatology practice. Its remarkable versatility is attested by its routine use in lupus, in patients with an autoimmune coagulopathy, in patients with rheumatoid arthritis, as well as in those with a low-level inflammatory
Read Article
First Look at COVID-19 Global Rheumatology Alliance Registry
Jun 01, 2020
Gianfresco et al have published the first peer-reviewed analysis of COVID-19 infected, rheumatic disease patients entered into the Rheumatology Global Alliance registry; showing that a) rheumatic disease patient can be infected with COVID-19, b) that DMARD and biologic use has no apparent effect
Read Article
Hydroxychloroquine Improves Survival in Lupus
May 26, 2020
Hydroxychloroquine (HCQ) has dominated the news in recent weeks, because of poor outcomes reported when used in COVID patients. Yet, a recent report reaffirms what rheumatologists have known for years - that HCQ use is associated with better outcomes in systemic lupus erythematosus, including
Read ArticleRecent Blogs
Rebuttals
Mar 15, 2021
Since the COVID vaccine rollout, more people have been eligible to receive the vaccine. However, not everyone chooses to get one. I have heard many reasons (aka excuses) from my patients who are vaccine hesitant.
Most come from people who are highly intelligent, and claimed that they will receive the vaccine but not yet. While I am not trying to force people to get vaccinated, I wanted to hear their side of the story and also ask that they hear mine.
Read Post
